Login / Signup

Diagnostic and Practical Challenges in Applying National Comprehensive Cancer Network Guidelines for Suspected Pathogenic TP53 Mosaicism.

Daniel I NathanTehilla E BranderJulie GoldDeborah PaulPaula KleinKit ChengJohnson M LiuBridget K Marcellino
Published in: JCO precision oncology (2024)
Benefits and limitations in using NCCN guidelines to distinguish TP53 CH from mosaic LFS.
Keyphrases
  • clinical practice
  • papillary thyroid
  • pulmonary embolism
  • squamous cell
  • quality improvement
  • squamous cell carcinoma
  • lymph node metastasis
  • childhood cancer